Let me understand this correctly... you want a finance / business analyst to comment on the FDA recent approval of a drug trial (based solely on safety, not efficacy)?
From a medical point of view? From a financial point of view? From a humanitarian point of view? What could you possibly hope to achieve with this "invitation to comment"?
It's pretty simple analysis:
Medically: it's safe (let's hope it's also effective)
Financial: Were not funding the trial - thank god
Humanitarian: Hope it works out for those poor kids.
invitation to madamanswer to comment, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.010(0.85%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.17 | $1.352M | 1.152M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1982 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 47719 | 11 |
View Market Depth
| Last trade - 11.12am 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |